Phosphagenics developing novel antipain patches; Transdermal drug delivery market poised for growth

> After announcing a $19.2M capital raising, Phosphagenics ($PPGNY) said in an update that it is developing a novel Oxymorphone patch and a Oxycodone patch to treat chronic pain. Release

> EastGate Acquisitions announced that it will expand its efforts to treat diabetes with the development of large-molecule drugs. The company will use its submicron platform technology. More

> The growth of the transdermal drug delivery market will continue at a CAGR of 9.92% over a 5-year period, according to TechNavio analysts. Report

Suggested Articles

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.

Kindeva, which produces inhalers, transdermal patches and other medical devices, is expanding operations in the St. Paul, Minnesota, area.